Carnegie Mellon University
In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 7, 2024), Carnegie Mellon University reported 6 stock positions worth $80.1 million. Its top holding was Duolingo (DUOL) at 98.7% of the portfolio, followed by Vera Therapeutics (VERA, 0.9%) and Longevity Health (0.3%). Compared with Q4 2023, it reduced 1. The biggest sale was Duolingo (DUOL, shares −1%).
- Most Recent 13F
- Q2 2026
- Location
- Pittsburgh, PA
- CIK
- 0001039067
- Portfolio Value
- $80.1M (Q1 2024)
- SEC Filing
- 0000898432-24-000377 ↗ filed May 7, 2024
Holdings Value
Holdings 6 stocks · $80.1M
| DUOL Duolingo | 98.73% | 358,314 | $79.0M | Reduce -1.1% |
| VERA Vera Therapeutics Inc. | 0.86% | 16,060 | $693K | No change |
| LONGEVITY HEALTH HLDGS INC filed as CARMELL CORPORATION | 0.33% | 103,061 | $264K | No change |
| PREDICTIVE ONCOLOGY INC | 0.03% | 10,358 | $26K | No change |
| NBSE Neubase Therapeutics Inc. | 0.03% | 46,970 | $21K | No change |
| IHT Innsuites Hospitality Trust | 0.02% | 10,000 | $13K | No change |
Portfolio Sells Q4 2023 → Q1 2024
| DUOL Duolingo | Reduce -1.1% | 98.73% | −0.40 |
Portfolio Buys Q4 2023 → Q1 2024
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 5 | $78.9M | QQQ, DUOL, IHT, AGPU, LONGEVITY HEALTH HLDGS INC |
| Q1 2026 | 5 | $64.3M | QQQ, DUOL, IHT, LONGEVITY HEALTH HLDGS INC, AGPU |
| Q4 2025 | 5 | $89.3M | DUOL, QQQ, IHT, AGPU, LONGEVITY HEALTH HLDGS INC |
| Q3 2025 | 5 | $131.6M | DUOL, QQQ, IHT, PREDICTIVE ONCOLOGY INC, LONGEVITY HEALTH HLDGS INC |
| Q2 2025 | 5 | $154.6M | DUOL, QQQ, IHT, LONGEVITY HEALTH HLDGS INC, PREDICTIVE ONCOLOGY INC |
| Q1 2025 | 6 | $129.0M | DUOL, QQQ, PDD, IHT, LONGEVITY HEALTH HLDGS INC |
| Q4 2024 | 6 | $136.7M | DUOL, QQQ, PDD, LONGEVITY HEALTH HLDGS INC, IHT |
| Q3 2024 | 4 | $96.9M | DUOL, LONGEVITY HEALTH HLDGS INC, IHT, PREDICTIVE ONCOLOGY INC |
| Q2 2024 | 4 | $73.9M | DUOL, LONGEVITY HEALTH HLDGS INC, IHT, PREDICTIVE ONCOLOGY INC |
| Q1 2024 | 6 | $80.1M | DUOL, VERA, LONGEVITY HEALTH HLDGS INC, PREDICTIVE ONCOLOGY INC, NBSE |